Strategies and new developments in the generation of patient-specific pluripotent stem cells.
about
Induction of MesP1 by Brachyury(T) generates the common multipotent cardiovascular stem cellRonin is essential for embryogenesis and the pluripotency of mouse embryonic stem cellsDifferences between cellular and molecular profiles of induced pluripotent stem cells generated from mouse embryonic fibroblastsMicroRNA-9 coordinates proliferation and migration of human embryonic stem cell-derived neural progenitorsMammalian Krüppel-like factors in health and diseasesChromatin structure and gene expression programs of human embryonic and induced pluripotent stem cellsDeconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicineThe transcriptional foundation of pluripotencyGeneration of human induced pluripotent stem cells by direct delivery of reprogramming proteinsNeuroprotective Transcription Factors in Animal Models of Parkinson DiseaseHow to make an oligodendrocyteA Current View of Functional Biomaterials for Wound Care, Molecular and Cellular TherapiesMesenchymal and induced pluripotent stem cells: general insights and clinical perspectivesInduced pluripotent stem cells as a disease modeling and drug screening platformThe genomic stability of induced pluripotent stem cellsHematopoietic stem cell engineering at a crossroadsOvercoming barriers to the clinical utilization of iPSCs: reprogramming efficiency, safety and qualityMolecular imaging in stem cell therapy for spinal cord injurySystems-based technologies in profiling the stem cell molecular framework for cardioregenerative medicineStochasticity and the molecular mechanisms of induced pluripotencyAtomic force mechanobiology of pluripotent stem cell-derived cardiomyocytesIntercellular transport of Oct4 in mammalian cells: a basic principle to expand a stem cell niche?Induction and enhancement of cardiac cell differentiation from mouse and human induced pluripotent stem cells with cyclosporin-AChromatin structure of pluripotent stem cells and induced pluripotent stem cells.Induced pluripotent stem cells as a model for accelerated patient- and disease-specific drug discovery.A review of induced pluripotent stem cell, direct conversion by trans-differentiation, direct reprogramming and oligodendrocyte differentiationMesenchymal stem cells: potential for therapy and treatment of chronic non-healing skin woundsModeling retinal degeneration using patient-specific induced pluripotent stem cellsEfficient generation of lens progenitor cells from cataract patient-specific induced pluripotent stem cellsRobust and highly-efficient differentiation of functional monocytic cells from human pluripotent stem cells under serum- and feeder cell-free conditionsHuman lymphoblastoid B-cell lines reprogrammed to EBV-free induced pluripotent stem cellsDissecting direct reprogramming through integrative genomic analysisStem cells, the molecular circuitry of pluripotency and nuclear reprogrammingSuppression of induced pluripotent stem cell generation by the p53-p21 pathwayStem cell platforms for regenerative medicineApplications of Microfluidics in Stem Cell Biology.Biomaterial technology for tissue engineering applications.Generation of functionally competent and durable engineered blood vessels from human induced pluripotent stem cells.Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neuronsHigh-efficiency stem cell fusion-mediated assay reveals Sall4 as an enhancer of reprogramming
P2860
Q24305182-F4394A1F-5BC3-41CA-9D75-6816B3B325B6Q24336456-7AED8DD1-E3A9-4032-AABE-9A44529E9478Q24569643-DAF5BD56-BB56-4EB0-B98D-E482B5AA33F0Q24601338-69844951-9119-4F1C-869A-7D3F47595AF9Q24612560-C7F6C564-F4FC-45E4-8DE2-16C4F120F44AQ24620932-18B8BF39-FB33-4966-8541-9309E9A705F7Q24646217-8247EBAC-3CAD-4D4F-982C-C0B4C6F3FA47Q24649039-FED86813-9F2D-48DC-AD07-A0662D7CEEC6Q24653753-491AA816-FEEE-4945-B51D-F185EB186D2EQ26765693-FD444CF7-E181-4425-83C0-2815A479341EQ26775534-1EA68CF1-7124-4A18-B887-6A89D604E819Q26778235-5B27A550-F8CC-4763-8EDA-120B273872BFQ26785623-9CB3B4E5-24C0-488C-9800-CD2C1BE81072Q26865689-1E6A408D-B884-4DD5-AA67-B5FA3A108A65Q26998764-10331665-DBA9-4C51-A543-7FC7D132D10BQ27001570-645000C4-832F-4539-A444-8BA7E073BD1AQ27014026-0C4DE185-499F-4D73-BF8C-C601B8970451Q27023747-CF31FD54-0B11-4AEC-A769-CAA063845242Q27024287-20E76A45-D2EF-4470-9FF1-527458DD9612Q27300697-29968FC9-02AC-4722-8BF1-F635142243DFQ27302347-FFF97738-50CB-40F9-83D6-63B2400F0F4EQ27308637-5733C002-7E34-4038-BCAE-A8CCA78955FBQ27437615-817524CB-631D-44C5-9887-1C8A074471E8Q27691396-F29355E9-242B-4477-AF13-3C06264DC9F1Q27693217-C50632FE-CF57-4082-80FA-52F342B20CABQ28078326-E6B97FF0-CAB0-4D1D-B372-1D0AD4AAE6AEQ28085040-6FF00C09-0DE7-4679-B865-03A3D9541E7EQ28477132-9C3874BD-2849-430C-B8DD-099D11226895Q28481381-752D5346-F605-484C-B99B-FA1CAD87B771Q28485950-FE6EA229-15C1-44B3-8F80-6BC9006F5D5AQ28656323-5D996D0F-B5B9-4A5E-95FC-BDB16A545371Q29614211-7B982BF6-0F11-402C-844E-8D99A1C2E94CQ29614416-7D863EB3-978E-4F57-B35E-9F32A8D482D4Q29619160-FEDB08F5-606A-4C20-8AEE-72886C08B0E5Q30381054-E216B3AB-E856-4433-ABEF-CFD83B2D9325Q30446483-0A051BBA-10F4-4C86-9939-F92D4A48AC45Q30489070-13561622-EE55-4FEA-82BB-FF4B07115C6FQ30542133-8437F2A5-2D45-47E4-BA1A-856EF1C8211DQ30543660-D605FB3B-419F-4D4E-8CA9-160AAEE5B7AFQ33328480-71264E6F-76A6-4812-811E-1CFAF8A2FE80
P2860
Strategies and new developments in the generation of patient-specific pluripotent stem cells.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Strategies and new development ...... ecific pluripotent stem cells.
@ast
Strategies and new development ...... ecific pluripotent stem cells.
@en
Strategies and new development ...... ecific pluripotent stem cells.
@nl
type
label
Strategies and new development ...... ecific pluripotent stem cells.
@ast
Strategies and new development ...... ecific pluripotent stem cells.
@en
Strategies and new development ...... ecific pluripotent stem cells.
@nl
prefLabel
Strategies and new development ...... ecific pluripotent stem cells.
@ast
Strategies and new development ...... ecific pluripotent stem cells.
@en
Strategies and new development ...... ecific pluripotent stem cells.
@nl
P1433
P1476
Strategies and new development ...... ecific pluripotent stem cells.
@en
P356
10.1016/J.STEM.2007.05.012
P407
P577
2007-06-01T00:00:00Z